The study objective was to analyse the costs and quality of life (QOL) of multiple sclerosis
(MS) related to disease severity in Sweden as part of a study in nine European countries …

This cost-of-illness analysis, based on information from 1101 patients in Switzerland, is part
of a Europe-wide cost-of-illness study in multiple sclerosis (MS). The objective was to …

Multiple sclerosis (MS) is a chronic progressive disease of the CNS causing disability and
neurological symptoms that carry a substantial burden. Previous Italian studies appear …

Background: To estimate the value of treatments in multiple sclerosis (MS)–where lifetime
costs and outcomes cannot be observed–outcome data have to be combined with cost data …

This cost-of-illness analysis based on information from 1.549 patients in The Netherlands is
part of a Europe-wide study on the costs of multiple sclerosis (MS). The objective was to …

Background Multiple sclerosis (MS) causes work disability and healthcare resource use, but
little is known about the distribution of the associated costs to society. Objectives We …

This cost-of-illness analysis is part of a Europe-wide study on the costs of multiple sclerosis
(MS) and is based on information from patients in Austria. The objective was to estimate the …

INTRODUCTION: Poor specific economic information are available for the different Multiple
Sclerosis (MS) courses: relapsing remitting (RRMS), secondary progressive (SPMS) and …

Multiple sclerosis (MS) is a disease of the central nervous system (CNS) that affects young
adults. Survival is long, more than 35 years, and consequently the disease has a huge …

Aims: To estimate costs of multiple sclerosis (MS) in a German cohort according to severity
of the disease and clinical symptoms. Methods: 144 patients were recruited from an MS …